[Form 4] Kenvue Inc. Insider Trading Activity

Rhea-AI Filing Summary

German American Bancorp, Inc. (GABC) filed a Form 4 reporting an insider equity grant. On 06/30/2025, Director Christina M. Ryan received 1,298 shares of restricted common stock at a price of $0 as part of the company’s non-employee director compensation plan. Following the award, Ryan beneficially owns 15,914.4331 shares. According to the filing, the restricted stock will vest on 07/01/2026. No derivative securities were reported, and the transaction was reported as a direct holding (ownership code “D”). The filing was signed by attorney-in-fact Bradley C. Arnett on 07/02/2025.

Positive

• Director Christina M. Ryan increased her direct holdings by 1,298 shares, modestly enhancing insider ownership alignment.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine director grant; minimal market impact.

This Form 4 documents a standard annual equity grant to non-employee Director Christina M. Ryan. The 1,298-share award represents a modest increase in insider ownership and brings her total direct holdings to roughly 15.9 k shares. Because the shares were granted at no cost under the board’s compensation policy and vest over one year, the filing signals ongoing governance alignment rather than a discretionary purchase. There is no open-market buying, selling, or derivative activity that would imply a change in insider sentiment. As such, the event is considered administratively routine and should not materially influence GABC’s valuation or trading dynamics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALLISON RICHARD E JR

(Last) (First) (Middle)

C/O 1 KENVUE WAY

(Street)

SUMMIT NJ 07901

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Kenvue Inc. [ KVUE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units(1)	(2)	06/30/2025		A		1,061		(2)	(2)	Common Stock	1,061	(1)	32,515.889(3)	D

Explanation of Responses:

1. Each Deferred Share Unit ("DSU") represents the right to receive one share of Issuer common stock.

2. The DSUs represent deferral of cash compensation under the Issuer's Amended and Restated Deferred Fee Plan for Directors and will be settled in shares of common stock following the reporting person's separation from service.

3. Includes DSUs acquired as dividend equivalents.

Remarks:

	/s/ Alla Berenshteyn, as attorney-in-fact	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the GABC Form 4 filed on 07/02/2025 disclose?

It disclosed that Director Christina M. Ryan received 1,298 restricted shares on 06/30/2025.

How many GABC shares does Christina M. Ryan own after the grant?

She beneficially owns 15,914.4331 shares.

When will the newly granted GABC restricted stock vest?

The restricted shares will vest on 07/01/2026.

Was there any cash consideration for the shares granted to the director?

No, the shares were issued at a price of $0 as part of director compensation.

Did the filing report any derivative security transactions?

No derivative securities were reported in this Form 4.